These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33407696)

  • 1. Clinical, biochemical and molecular phenotype of congenital disorders of glycosylation: long-term follow-up.
    Bogdańska A; Lipiński P; Szymańska-Rożek P; Jezela-Stanek A; Rokicki D; Socha P; Tylki-Szymańska A
    Orphanet J Rare Dis; 2021 Jan; 16(1):17. PubMed ID: 33407696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyopathy, an uncommon phenotype of congenital disorders of glycosylation: Recommendations for baseline screening and follow-up evaluation.
    Zemet R; Hope KD; Edmondson AC; Shah R; Patino M; Yesso AM; Berger JH; Sarafoglou K; Larson A; Lam C; Morava E; Scaglia F
    Mol Genet Metab; 2024 Jun; 142(4):108513. PubMed ID: 38917675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II.
    Al Teneiji A; Bruun TU; Sidky S; Cordeiro D; Cohn RD; Mendoza-Londono R; Moharir M; Raiman J; Siriwardena K; Kyriakopoulou L; Mercimek-Mahmutoglu S
    Mol Genet Metab; 2017 Mar; 120(3):235-242. PubMed ID: 28122681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel N-Tetrasaccharide in Patients with Congenital Disorders of Glycosylation, Including Asparagine-Linked Glycosylation Protein 1, Phosphomannomutase 2, and Mannose Phosphate Isomerase Deficiencies.
    Zhang W; James PM; Ng BG; Li X; Xia B; Rong J; Asif G; Raymond K; Jones MA; Hegde M; Ju T; Cummings RD; Clarkson K; Wood T; Boerkoel CF; Freeze HH; He M
    Clin Chem; 2016 Jan; 62(1):208-17. PubMed ID: 26430078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital disorders of glycosylation with emphasis on cerebellar involvement.
    Barone R; Fiumara A; Jaeken J
    Semin Neurol; 2014 Jul; 34(3):357-66. PubMed ID: 25192513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum transferrin carrying the xeno-tetrasaccharide NeuAc-Gal-GlcNAc2 is a biomarker of ALG1-CDG.
    Bengtson P; Ng BG; Jaeken J; Matthijs G; Freeze HH; Eklund EA
    J Inherit Metab Dis; 2016 Jan; 39(1):107-14. PubMed ID: 26335155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALG1-CDG: a new case with early fatal outcome.
    Rohlfing AK; Rust S; Reunert J; Tirre M; Du Chesne I; Wemhoff S; Meinhardt F; Hartmann H; Das AM; Marquardt T
    Gene; 2014 Jan; 534(2):345-51. PubMed ID: 24157261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Population-Based Study on Congenital Disorders of Protein N- and Combined with O-Glycosylation Experience in Clinical and Genetic Diagnosis.
    Pérez-Cerdá C; Girós ML; Serrano M; Ecay MJ; Gort L; Pérez Dueñas B; Medrano C; García-Alix A; Artuch R; Briones P; Pérez B
    J Pediatr; 2017 Apr; 183():170-177.e1. PubMed ID: 28139241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver involvement in congenital disorders of glycosylation (CDG). A systematic review of the literature.
    Marques-da-Silva D; Dos Reis Ferreira V; Monticelli M; Janeiro P; Videira PA; Witters P; Jaeken J; Cassiman D
    J Inherit Metab Dis; 2017 Mar; 40(2):195-207. PubMed ID: 28108845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient glycan extension and endoplasmic reticulum stresses in ALG3-CDG.
    Daniel EJP; Edmondson AC; Argon Y; Alsharhan H; Lam C; Freeze HH; He M
    J Inherit Metab Dis; 2024 Jul; 47(4):766-777. PubMed ID: 38597022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature.
    Schiff M; Roda C; Monin ML; Arion A; Barth M; Bednarek N; Bidet M; Bloch C; Boddaert N; Borgel D; Brassier A; Brice A; Bruneel A; Buissonnière R; Chabrol B; Chevalier MC; Cormier-Daire V; De Barace C; De Maistre E; De Saint-Martin A; Dorison N; Drouin-Garraud V; Dupré T; Echenne B; Edery P; Feillet F; Fontan I; Francannet C; Labarthe F; Gitiaux C; Héron D; Hully M; Lamoureux S; Martin-Coignard D; Mignot C; Morin G; Pascreau T; Pincemaille O; Polak M; Roubertie A; Thauvin-Robinet C; Toutain A; Viot G; Vuillaumier-Barrot S; Seta N; De Lonlay P
    J Med Genet; 2017 Dec; 54(12):843-851. PubMed ID: 28954837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome-encapsulated mannose-1-phosphate therapy improves global N-glycosylation in different congenital disorders of glycosylation.
    Budhraja R; Radenkovic S; Jain A; Muffels IJJ; Ismaili MHA; Kozicz T; Pandey A; Morava E
    Mol Genet Metab; 2024 Jun; 142(2):108487. PubMed ID: 38733638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital disorder of glycosylation type Id (CDG Id): phenotypic, biochemical and molecular characterization of a new patient.
    Rimella-Le-Huu A; Henry H; Kern I; Hanquinet S; Roulet-Perez E; Newman CJ; Superti-Furga A; Bonafé L; Ballhausen D
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S381-6. PubMed ID: 18679822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitotic Intragenic Recombination: A Mechanism of Survival for Several Congenital Disorders of Glycosylation.
    Kane MS; Davids M; Adams C; Wolfe LA; Cheung HW; Gropman A; Huang Y; ; Ng BG; Freeze HH; Adams DR; Gahl WA; Boerkoel CF
    Am J Hum Genet; 2016 Feb; 98(2):339-46. PubMed ID: 26805780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of congenital disorders of glycosylation by capillary zone electrophoresis of serum transferrin.
    Carchon HA; Chevigné R; Falmagne JB; Jaeken J
    Clin Chem; 2004 Jan; 50(1):101-11. PubMed ID: 14633925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of CDG diagnosis by combined examination of several glycoproteins.
    Fang J; Peters V; Assmann B; Körner C; Hoffmann GF
    J Inherit Metab Dis; 2004; 27(5):581-90. PubMed ID: 15669673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALG1-CDG: Clinical and Molecular Characterization of 39 Unreported Patients.
    Ng BG; Shiryaev SA; Rymen D; Eklund EA; Raymond K; Kircher M; Abdenur JE; Alehan F; Midro AT; Bamshad MJ; Barone R; Berry GT; Brumbaugh JE; Buckingham KJ; Clarkson K; Cole FS; O'Connor S; Cooper GM; Van Coster R; Demmer LA; Diogo L; Fay AJ; Ficicioglu C; Fiumara A; Gahl WA; Ganetzky R; Goel H; Harshman LA; He M; Jaeken J; James PM; Katz D; Keldermans L; Kibaek M; Kornberg AJ; Lachlan K; Lam C; Yaplito-Lee J; Nickerson DA; Peters HL; Race V; Régal L; Rush JS; Rutledge SL; Shendure J; Souche E; Sparks SE; Trapane P; Sanchez-Valle A; Vilain E; Vøllo A; Waechter CJ; Wang RY; Wolfe LA; Wong DA; Wood T; Yang AC; ; Matthijs G; Freeze HH
    Hum Mutat; 2016 Jul; 37(7):653-60. PubMed ID: 26931382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening using serum percentage of carbohydrate-deficient transferrin for congenital disorders of glycosylation in children with suspected metabolic disease.
    Pérez-Cerdá C; Quelhas D; Vega AI; Ecay J; Vilarinho L; Ugarte M
    Clin Chem; 2008 Jan; 54(1):93-100. PubMed ID: 18024528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H/F119L genotype.
    Kjaergaard S; Schwartz M; Skovby F
    Arch Dis Child; 2001 Sep; 85(3):236-9. PubMed ID: 11517108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital disorders of glycosylation.
    Jaeken J
    Ann N Y Acad Sci; 2010 Dec; 1214():190-8. PubMed ID: 21175687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.